Researchers at the University of California, San Francisco propose modifications to informed consent procedures in psychedelic drug trials, aiming to balance scientific rigor and ethical standards.
Researchers examined associations between body composition factors, such as fat and muscle mass, and health-related quality of life outcomes in patients with knee and hip osteoarthritis.